// SECTOR DOSSIER
pharmaceuticals Unicorns
Every pharmaceuticals unicorn we track — 4 private companies valued $1B or more, tiered by paper valuation. Combined balance sheet myth: $40B.
TIER 2 // PRIORITY TARGETS
The Decacorns $10B – $99B · 2
TIER 3 // STANDING HORDE